DOTMV·shop.mvrent.mvEN
Explore
MedicinePOM

Vericiguat

A heart failure tablet that reduces the risk of cardiovascular death and hospitalisation.

Clinical information

Common uses

  • chronic heart failure with reduced ejection fraction after recent hospitalisation

Common side effects

  • low blood pressure
  • anaemia

Cautions

  • must not be taken in pregnancy — pregnancy test before starting
  • effective contraception needed during and one month after treatment

Interactions

  • other soluble guanylate cyclase stimulators — must not be combined
  • PDE-5 inhibitors (e.g. sildenafil) — not recommended

Pregnancy: avoid — contraindicated; may cause fetal harm

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, vericiguat (Verquvo) label, setid 17056d73-1b1b-4bf2-9c07-b7a9367f0d6d (accessed 2026-08-16)

Approved brands & formulations3

Brand nameDosage formStrengthImporterCategory
Verquvo™ 10mgTablet ( Film coated )10mgState Trading Organization PlcPOM
Verquvo™ 2.5mgTablet ( Film coated )2.5mgState Trading Organization PlcPOM
Verquvo™ 5mgTablet ( Film coated )5mgState Trading Organization PlcPOM
Old search API